T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer
T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer
Not yet recruiting · NCT06548178 · Registry updated 2024-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer | HER2-positive Breast Cancer | Not yet recruiting | Phase 2 | 2024-08-12 | NCT06548178 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 257 |